SCIENTIFIC BACKGROUND

FMR1

With up to 40%, ovarian disorders are among the most important infertility factors in women. Premature ovarian insufficiency (POI) manifests itself as secondary amenorrhea and occurs in about 1% of all women before the age of 40. The cause is a disturbance in the hypothalamic-pituitary-ovarian regulatory circuit. Biochemically, it is characterized by hypergonadotropic hypogonadism. This constellation results in climacteric symptoms (climacterium praecox) and, in some cases, other neurological, metabolic, and cardiovascular symptoms in addition to infertility.

 

The causes are as follows:

 

  • Genetic factors: implicated in about 20-25% of cases
  • Autoimmune reactions: causing approximately 10-15% of cases
  • Iatrogenic causes: responsible for 30-40% of cases
  • Idiopathic reasons: accounting for 40-60% of cases

 

Different genes on the X chromosome contribute to ovarian function. POI occurs, for example, in 4-5% of women with Ullrich-Turner syndrome who did not have primary amenorrhea and in partial X monosomies.

 

Premutations (CGG repeat of 55-200 repeats) in the FMR1 gene are currently the most common cause of premature ovarian failure, accounting for 10-15%. Approximately 20% of all premutation carriers develop POI. In women with sporadic POI, premutations are found in 0.8-7.5% of cases. In women with familial POI, the frequency of a premutation is up to 13%. Genetic counseling is indicated in those of childbearing potential, as there is both an increased risk of having children with fragile X syndrome and a risk of onset of menopause before the childbearing potential is realized.

 

In another candidate gene, BMP15 (Human Bone Morphogenetic Protein-15, region Xp11.2), a relevant pathogenic variant was detected in 2% of women with POI. The gene contains two exons and encodes an oocyte-specific growth and differentiation factor that stimulates follicle genesis and granulosa cell growth.

 

Pathogenic variants in the follicle-stimulating hormone receptor (FSHR) gene have been detected in patients with premature ovarian failure. This gene is located on chromosome 2p21-p16 and consists of 10 exons. The intact receptor is a prerequisite for normal gonadal development, germ cell production and sexual maturation at puberty.

 

Furthermore, pathogenic variants have been described in a number of other genes associated with POI, each with a diagnostic sensitivity of 1-2%. Analysis of the genes BMP15, FSHR as well as INHA, DIAPH2, FOXL2, NOBOX, FIGLA, NR5A1, STAG3, SOHLH1, SOHLH2, GDF9, LHCGR and ESR1 can be requested as part of a gene panel.

 

References
Rossetti et al. 2017, Clin Genet 91: 183 / Ledig et Wieacker 2011, Med Gent 2:237 / Rossetti et al. 2009, Hum Mutat 30:804 / Lussiana et al. 2008, Obstet Gynecol Surv 63:785 / Dixit et al. 2006, Hum Genet 119:408 / Layman 2006, J Clin Endocrinol Metab 91:1673

GENES

FMR1

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Neurodevelopmental disorders (NDDs) have diverse genetic origins, making diagnosis challenging. A new study analyzing over 1,100 pediatric patients f...

Read more

Colorectal cancer (CRC) remains one of the most prevalent and deadly cancers worldwide, with a significant number of cases presenting at an advanced ...

Read more

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inherited diso...

Read more

Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of two. The co...

Read more

The human brain develops through a complex series of events, with genes carefully regulating the formation of neurons and glial cells. A recent study...

Read more

Rare diseases affect between 300 and 400 million people worldwide – more than cancer and AIDS combined [1, 2], but despite this, many people face a...

Read more

Rosalind Elsie Franklin was a brilliant and meticulous research scientist whose interdisciplinary work made fundamental contributions to various area...

Read more

February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th...

Read more

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor...

Read more

Antimicrobial resistance (AMR) is one of the most pressing global health threats, and accurate identification and surveillance of multidrug-resistant...

Read more